LMT vs MGRX · P/E 20, rev $20.06B vs rev $456.0K
Lockheed Martin Corporation (LMT) versus Mangoceuticals, Inc. Common Stock (MGRX) — a side-by-side from cached financials, not a winner call.
Lockheed Martin Corporation (LMT) is a aerospace & defense company listed on US. It is led by Jim Taiclet.
Mangoceuticals, Inc. Common Stock (MGRX) is a health information services company listed on US.
Latest reported LMT revenue for 2026-06-28 was $20.06B. Net income was $1.84B. Revenue was up 11.3% from 2026-03-29 to 2026-06-28. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
Latest reported MGRX revenue for 2025-12-31 was $456.0K. Net income was -$20.6M. Revenue was down 26.0% from 2024-12-31 to 2025-12-31. MGRX currently screens at market cap $16.3M.
LMT currently screens at market cap $108.37B and trailing P/E 19.9. MGRX currently screens at market cap $16.3M.
Not investment advice. Open the LMT and MGRX stock pages for the full models.
Not investment advice.